INNATE PHARMA |
Market Closed -
Other stock markets
|
After market 12:17:16 pm | |||
| 2.525 EUR | -0.20% |
|
2.518 | -0.28% |
| May. 24 | Innate Pharma: five abstracts selected for ASCO | CF |
| May. 14 | Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 222M | - | |||||
| 54.63B | - | |||||
| 39.92B | ||||||
| 38.82B | ||||||
| 26.86B | ||||||
| 26.22B |
- Stock Market
- Equities
- IPH Stock
- Charts Innate Pharma
- Sector Chart
